ArticleHypoxia (Auckland, N.Z.)2017

KEMTUB012-NI2, a novel potent tubulysin analog that selectively targets hypoxic cancer cells and is potentiated by cytochrome p450 reductase downregulation.

Paolo Lazzari et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.